| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/09/2014 | WO2014005900A1 Dye composition comprising a cationic meta-phenylenediamine |
| 01/09/2014 | WO2012164324A9 Novel processes for the preparation of prostaglandin amides |
| 01/09/2014 | US20140012012 Polyether compound and electrolyte composition |
| 01/09/2014 | US20140011851 Novel crystals and process of making 5-(-METHYL)-2-METHOXY-BENZOIC ACID |
| 01/08/2014 | EP2682486A1 Cobalt extraction method |
| 01/08/2014 | EP2682095A1 Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use |
| 01/08/2014 | CN103502244A Compound for increasing kinase active and application thereof |
| 01/08/2014 | CN103502222A Chromophores with perfluoroalkyl substituents |
| 01/08/2014 | CN103497160A Chiral amine functional ionic liquid and preparation thereof |
| 01/08/2014 | CN103497159A Method for preparing 1, 2-disubstituted-5-sulfonyl imidazole compounds |
| 01/08/2014 | CN103497158A Preparation method and application of 1-allyl,3-methylimidazole room-temperature ionic liquid |
| 01/08/2014 | CN103497157A 2-imidazolidone synthesis method |
| 01/08/2014 | CN103497114A NMDA receptor antagonists for neuroprotection |
| 01/08/2014 | CN102459162B Novel cyclopentane derivatives |
| 01/08/2014 | CN102285921B New industrial production process for synthesizing imidazole-2-aldehyde or derivatives of imidazole-2-aldehyde by using imidazole or derivatives of imidazole |
| 01/07/2014 | US8623942 Epoxy resin composition, curing agent, and curing accelerator |
| 01/07/2014 | US8623900 Amino alcohol derivatives and their therapeutic activities |
| 01/07/2014 | US8623661 Iron chelating agent, method for producing same, method for determining amount of iron ions and method for trapping iron ions |
| 01/07/2014 | CA2560922C Improvements in or relating to compounds for use in the treatment of aids and other viral diseases and hiv-related infections and compositions containing such compounds, methods of treating such diseases and infections and methods of making such compounds and compositions |
| 01/03/2014 | CA2875461A1 3-o-heteroaryl-ingenol |
| 01/02/2014 | US20140005244 Family of polyamine arylethylamide compounds, and their cosmetic or dermocosmetic use |
| 01/01/2014 | CN103492368A Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
| 01/01/2014 | CN103483265A Metronidazole production method |
| 01/01/2014 | CN103483264A Energetic ion salts of 1-nitramine-2, 4-dimetridazloe and preparation method thereof |
| 01/01/2014 | CN102036987B Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof |
| 12/31/2013 | US8618308 Process for the preparation of 4-(1-hydroxy-1-methylethyl)-2-propyl-imidazole-5-carboxylates |
| 12/31/2013 | US8618169 Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
| 12/31/2013 | US8618154 LXR modulators |
| 12/31/2013 | US8618144 Pyrrolidine-derived beta 3 adrenergic receptor agonists |
| 12/31/2013 | US8618122 Compound having acidic group which may be protected, and use thereof |
| 12/31/2013 | CA2666246C Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid |
| 12/27/2013 | WO2013192005A2 Differentiation of human embryonic stem cells into pancreatic endocrine cells |
| 12/27/2013 | WO2013190510A2 NOVEL 2,3-DIHYDRO-1H-IMIDAZO{1,2-a}PYRIMIDIN-5-ONE and this1,2,3,4-TETRAHYDROPYRIMIDO{1,2-a}PYRIMIDIN-6-ONE DERIVATIVES COMPRISING A SUBSTITUTED MORPHOLINE, PREPARATION THEREOF AND PHARMACEUTICAL USE THEREOF |
| 12/27/2013 | WO2013190482A1 Resorcinol derivatives and their cosmetic application |
| 12/27/2013 | WO2013030068A4 Method for producing a methionine salt |
| 12/27/2013 | CA2877089A1 Novel 2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof |
| 12/27/2013 | CA2876671A1 Treatment of pluripotent cells |
| 12/26/2013 | US20130345437 Process for preparing biphenyl imidazole compounds |
| 12/25/2013 | EP2677560A1 Organic electroluminescence element and illumination device |
| 12/25/2013 | EP2344437B1 Process for producing alpha-hydroxyketone compounds |
| 12/25/2013 | EP2173707B1 Pleuromutilin derivatives and their use as antimicrobials |
| 12/25/2013 | EP2152670B1 Bridged six-membered ring compounds |
| 12/25/2013 | CN103467749A Hyperbranched polymer with -C-N- flexible chain structure, compound curing agent and preparation method thereof |
| 12/25/2013 | CN103467385A Monocyclic heteroaryl compounds |
| 12/25/2013 | CN103467384A Novel carboxylic acid functional rhenium iron liquid and preparation method and application thereof |
| 12/25/2013 | CN103467383A Conjugate of paeonol and ozagrel, pharmaceutical composition and medical application of conjugate |
| 12/25/2013 | CN103467382A Method for preparing thiocyanate-containing ionic liquid and application of ionic liquid in polyacrylonitrile spinning processing |
| 12/25/2013 | CN102321028B Method for synthesizing 2-methyl-5-nitroimidazole-1-ethanol |
| 12/25/2013 | CN101795997B Distillation of ionic liquids |
| 12/24/2013 | US8614213 Cyclohexyl amide derivatives and their use as CRF-1 receptor antagonists |
| 12/24/2013 | CA2560047C Substituted imidazoles and their use as opioid receptor modulators |
| 12/19/2013 | WO2013187503A1 Glycine transporter inhibitor |
| 12/19/2013 | US20130338372 Substituted Imidazoline Compounds |
| 12/18/2013 | EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation |
| 12/18/2013 | EP2673260A1 Glucagon receptor modulator |
| 12/18/2013 | EP2673250A2 Stilbene analogs and methods of treating cancer |
| 12/18/2013 | EP2445868B1 Biphenyl amides useful as p2x3 and/or p2x2/3 receptors modulators |
| 12/18/2013 | EP2374807B1 An improved process for the isolation of temozolomide |
| 12/18/2013 | CN203342799U Pressure-relief buffer tank applied to hydantoin production equipment |
| 12/18/2013 | CN203342781U Pipeline-type reactor applied to hydantoin production equipment |
| 12/18/2013 | CN203342767U Gas-liquid distribution device applied to hydantoin production equipment |
| 12/18/2013 | CN103459573A Equilibrated dynamic mixtures to control the release of perfuming aldehydes and ketones |
| 12/18/2013 | CN103450092A Synthesis and preparation method of metronidazole-sulfanilamide derivatives |
| 12/18/2013 | CN103450091A Imidazole derivatives, preparation method and applications thereof |
| 12/18/2013 | CN103450090A Method for preparing N-(3-aminopropyl) imidazole |
| 12/18/2013 | CN103450089A Preparation method of 4-phenylimidazole |
| 12/18/2013 | CN103450088A Novel sulfonic acid functionalized rhenium ionic liquid and preparation method and application thereof |
| 12/18/2013 | CN103450087A Preparation method of paeonol and ozagrel conjugate |
| 12/18/2013 | CN103450086A Ozagrel compound, preparation method and pharmaceutical composition of ozagrel compound |
| 12/17/2013 | US8609865 Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-yl)-ethyl]-amino}-methyl)-2-methoxy-benzoic acid |
| 12/17/2013 | US8609859 One pot process for preparing 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan) |
| 12/17/2013 | US8609839 Camphor-derived compounds, method for manufacturing the same, and application thereof |
| 12/17/2013 | US8609709 Compounds as opioid receptor modulators |
| 12/17/2013 | US8609708 Synthetic compounds and derivatives as modulators of smoking or nicotine ingestion and lung cancer |
| 12/17/2013 | US8609572 Basic ionic liquids |
| 12/12/2013 | WO2013184202A1 Fbxo3 inhibitors |
| 12/12/2013 | WO2013183808A1 Acid-functionalized imidazolium ionic liquid for separating carbon dioxide and use thereof |
| 12/12/2013 | WO2012170889A9 Cleavable lipids |
| 12/12/2013 | US20130331421 Specific diarylhydantoin and diarylthiohydantoin compounds |
| 12/12/2013 | CA2875305A1 Fbxo3 inhibitors |
| 12/11/2013 | EP2671581A2 Compositions and methods for treating cancer |
| 12/11/2013 | EP2670728A2 Process for producing alpha-hydroxyketone compound |
| 12/11/2013 | CN103443083A Cancer targeting using carbonic anhydrase isoform IX inhibitors |
| 12/11/2013 | CN103443082A Prodrugs of LXR modulating imidazole derivatives |
| 12/11/2013 | CN103443081A Imidazole compound production method, imidazole compound, imidazole-based compound, organic metal complex, material for organic electroluminescent element, organic electroluminescent element, display device, and lighting device |
| 12/11/2013 | CN103443068A Insecticidal compounds |
| 12/11/2013 | CN103435606A CDK2 and CSK3beta dual inhibitor and application thereof |
| 12/11/2013 | CN103435524A N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/11/2013 | CN103435448A High-stereoselectivity method for reducing alkynylamines |
| 12/10/2013 | US8604073 Antimicrobial composition |
| 12/10/2013 | US8604056 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor XIa inhibitors |
| 12/05/2013 | WO2013178065A1 Amino acid copper complex with effects of preventing alopecia, growing hair and protecting skin, preparation method and application |
| 12/05/2013 | US20130324540 Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents |
| 12/05/2013 | US20130324506 New 6,11-dihydro-5H-benzo[d]imidazo[1,2-a]azepines derivatives as histamine H4 receptor ligands |
| 12/04/2013 | EP2669741A1 Charge control agent and toner using same |
| 12/04/2013 | EP2489350B1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 12/04/2013 | CN103420916A Rapid preparation method for 1,2,3,4,5-tetra-substituted imidazole compound |
| 12/04/2013 | CN103420915A Preparation method of 1-substituent-3-methylimidazole acetate ionic liquid |
| 12/04/2013 | CN102532062B Benzoyl urea compound and synthesis method thereof |
| 12/04/2013 | CN102391186B Method for preparing ozagrel intermediate (E)-4-(methyl imidazolyl) methyl cinnamate |